Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,738
datasets available to search
ShareScore release 0.9.0
Dataset results
2,738 results for “Multiple Sclerosis”
A Study of the Safety and Effectiveness of Sativex®, for the Relief of Symptoms of Spasticity in Subjects, From Phase B, With Multiple Sclerosis (MS)
ClinicalTrials.gov study NCT00681538. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Sativex in the Treatment of Central Neuropathic Pain Due to Multiple Sclerosis
ClinicalTrials.gov study NCT01604265. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Efficacy Extension Study of Daclizumab High Yield Process (DAC HYP) in Participants With Multiple Sclerosis Who Have Completed Study 205MS201 (NCT00390221) to Treat Relapsing-Remitting Mult
ClinicalTrials.gov study NCT00870740. IPD Sharing: Not stated. Countries: 8. Publications: 2.
Evaluate the Maintenance of Effect After Long-term Treatment With Sativex® in Subjects With Symptoms of Spasticity Due to Multiple Sclerosis
ClinicalTrials.gov study NCT00702468. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Examining a Wheelchair Exercise-training Intervention for Persons With Multiple Sclerosis
ClinicalTrials.gov study NCT05888727. IPD Sharing: NO. Countries: 1. Publications: 1.
Aspirin for Exercise in Multiple Sclerosis (ASPIRE)
ClinicalTrials.gov study NCT03824938. IPD Sharing: YES. Countries: 1. Publications: 2.
Open-Label Study to Assess the Effect of Long-Term Prolonged-Release Fampridine (BIIB041) on Quality of Life as Reported by Participants With Multiple Sclerosis
ClinicalTrials.gov study NCT01480076. IPD Sharing: Not stated. Countries: 9. Publications: 1.
Phase 3 Efficacy and Safety Study of BG00012 in Pediatric Subjects With Relapsing-remitting Multiple Sclerosis (RRMS)
ClinicalTrials.gov study NCT02283853. IPD Sharing: YES. Countries: 18. Publications: 1.
MRI Trial to exPlore the efficAcy and Safety of IMU-838 in Relapsing Remitting Multiple Sclerosis (EMPhASIS)
ClinicalTrials.gov study NCT03846219. IPD Sharing: Not stated. Countries: 4. Publications: 2.
Wearable Lower Extremity Exoskeleton to Promote Walking in Persons With Multiple Sclerosis
ClinicalTrials.gov study NCT02519244. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of FTY720 in Patients With Relapsing Multiple Sclerosis
ClinicalTrials.gov study NCT00333138. IPD Sharing: Not stated. Countries: 11. Publications: 2.
Simvastatin in Secondary Progressive Multiple Sclerosis
ClinicalTrials.gov study NCT03896217. IPD Sharing: NO. Countries: 1. Publications: 37.
A Phase II Study Comparing Low- and High-Dose Alemtuzumab and High-Dose Rebif® in Patients With Early, Active Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT00050778. IPD Sharing: Not stated. Countries: 5. Publications: 12.
Function Magnetic Resonance Imaging to Assess Two Therapeutic Strategies in Multiple Sclerosis (NeuroRehEM).
ClinicalTrials.gov study NCT05270239. IPD Sharing: NO. Countries: 1. Publications: 6.
Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
ClinicalTrials.gov study NCT01895335. IPD Sharing: Not stated. Countries: 14. Publications: 2.
Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis
ClinicalTrials.gov study NCT00289978. IPD Sharing: Not stated. Countries: 19. Publications: 9.
Tolerability of Acthar for the Treatment of Multiple Sclerosis in Relapses (TAMS)
ClinicalTrials.gov study NCT02258217. IPD Sharing: Not stated. Countries: 1. Publications: 12.
Evaluate the Safe and Effective Use of the Avonex® Single-Use Autoinjector in Multiple Sclerosis Subjects
ClinicalTrials.gov study NCT00828204. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Pilot Study of Lithium in Progressive Multiple Sclerosis
ClinicalTrials.gov study NCT01259388. IPD Sharing: NO. Countries: 1. Publications: 1.
Efficacy and Safety of Oral BG00012 in Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT00420212. IPD Sharing: Not stated. Countries: 29. Publications: 11.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.